Download Center

Bond Listing with a Foreign Approved Prospectus

Fast and Easy Access to the Swiss Debt Capital Market with a Foreign Approved Prospectus.

Open document

CONNEXOR

CONNEXOR allows for fully automated, cost-efficient management of reference data throughout a financial instrument's entire life cycle.

Open document

CONNEXOR Auto-ICPY Service

Fully automated IBE Income Payment instructions for Structured Products with fixed coupons

Open document

CONNEXOR Bondfloor Automation Service

Automated reporting service to the Swiss Federal Tax Administration

Open document

CONNEXOR Events

CONNEXOR Events is a service that allows issuers to automate their reporting processes for structured products, thereby making it easier to submit product event information electronically.

Open document

CONNEXOR Excel Converter Service

Optimize Your Submission Workflow

Open document

CONNEXOR® Distribution

Provisions

Open document

Enjoy the Benefits of Europe’s Leading Exchange for Life Sciences Companies

The Swiss Stock Exchange represents more than a third of the European Life Sciences market capitalization.

Open document

ETF Listing Process

List your ETFs easily and well guided on SIX Swiss Exchange

Open document

ETP Listing Process

List your ETPs easily and well guided on SIX Swiss Exchange

Open document

Evaluating the Aspects of a Swiss versus a US Listing

Why look further afield when you can have it in Switzerland?

Open document

FuW: 14 Kandidaten schnuppern am IPO, German

Die Schweizer Börse macht in der Sparks Academy hiesigen Start-ups aus verschiedenen Branchen einen Börsengang schmackhaft.

Open document

Galderma Case Study

Open document

Go Public on SIX Swiss Exchange and Concurrently Access the US Capital Markets

By including a Rule 144A offering in your company’s IPO on SIX Swiss Exchange, you have the advantage of being able to access the US capital markets. This could help maximize the value of your company going public.

Open document

Going Public Media; Plattform Life Science Biotechnologie 2020, German

Die Schweizer Börse ist die führende europäische Börse für IPOs von Life Sciences Unternehmen

Open document

GoingPublic Magazine 2019: Special - Capital Market Switzerland

“Capital-rich investors create a good base for IPOs”

Open document

How SIX Swiss Exchange’s position as the leading European biotech exchange can help achieve global sustainability goals

Open document

Investor Relations Handbook: Compact Guide

As a share issuer and as a company primarily listed on the Swiss Stock Exchange, you have important information obligations towards your investors and the public. These duties serve to ensure continuous transparency about your company.

Open document

IPO Academy Program

Open document

IPO Academy Program

Open document

List Your Company Efficiently with Our Going Public Process

As an equity issuer, SIX offers you a complete package comprising everything you need for admission to the exchange. Our process for going public features short decision-making pathways, flexibility and reliability as well as close proximity to markets and customers. Expert contacts and helpful information support you throughout the whole process of going public.

Open document

Our Checklist Supports Your Being Public

As an equity issuer and primary listed company, you have a number of important duties to fulfil as regards informing your investors and the general public. These obligations for maintaining a listing serve to ensure transparency over your company at all times.

Open document

Plattform Life Sciences-Biotechnologie 2022; Sparks provides a welcome springboard for biotech SMEs on SIX Swiss Exchange

Open document

Primary Swiss Debt Capital Market Information Q2 2024

Open document

Provisions CONNEXOR® Listing

Open document

Quick Style Guide

Sustainability is Increasingly in the Spotlight

Open document

Raising Capital Efficiently

The Bond Listing Guide of the SIX Swiss Exchange.

Open document

Schweizer Jahrbuch für Strukturierte Produkte 2019, German

Open document

Schweizer Jahrbuch für Strukturierte Produkte 2020, German

Open document

Securing Fair and Transparent Protection Offered by the Swiss Takeover Rules Through Being Listed on SIX

If a company lists its equity securities on a foreign exchange, this may have far-reaching implications with respect to takeover protection. The Swiss takeover rules only apply to companies respectively equity securities that have a primary listing on a Swiss exchange. Subsequently, a Swiss incorporated company being listed on a foreign exchange may be vulnerable to unsolicited takeovers.

Open document

SIX 1.5°C Climate Equity – Framework

Open document

SIX 1.5°C Climate Equity: Questions & Answers

Open document

SIX Sustainability Handbook

Open document

Sparks IPO Academy

Open document

Sparks: The SIX Swiss Exchange SME Exchange

Open document

Special Capital Market Switzerland 2020: The new Swiss prospectus regime

What an IPO candidate needs to know

Open document

Special «Kapitalmarkt Schweiz 2021»: Sparks Explained

Everything you need to know about the new SME segment.

Open document

Startup Magazine 2021: “Make Way for Sparks!”

Everything you need to know about the new SME stock exchange.

Open document

Swiss Biotech Association; Swiss Biotech Report 2019

Hero and bogeyman: The public face of leadership after an IPO

Open document

Swiss Biotech Association; Swiss Biotech Report 2020

Five-year stellar performance by Switzerland’s SXI Bio+Medtech Index

Open document

Swiss Biotech Report 2016

Record year for funding.

Open document

Swiss Biotech Report 2017

Reducing complexity as a function of strategy.

Open document

Swiss Biotech Report 2018

Retrospective: Biotech listings on SIX Swiss Exchange

Open document

Swiss Biotech Report 2020

Five-year stellar performance by SXI Bio+Medtech Index

Open document

Swiss Biotech Report 2021

SIX-listed biotechs light up exceptional trading year

Open document

Swiss Biotech report 2022

Sparks provides a welcome springboard for biotech SMEs on SIX Swiss Exchange

Open document

Swiss Biotech Report 2023

SIX Swiss Exchange: A safe haven in stormy times

Open document

Take Your Family Business to the Next Level. List on the Swiss Stock Exchange.

Lay the foundation for a seamless and transparent succession by going public with your family business.

Open document

The New Swiss Prospectus Regime

What You as an IPO Candidate Need to Know.

Open document

Usage Agreement CONNEXOR® Distribution

Open document

Usage Agreement CONNEXOR® Listing

Open document

Welcome to the Swiss Financial Center

Your Place for Raising Capital Efficiently.

Open document